Quarterly report pursuant to Section 13 or 15(d)

Patents (Details Narrative)

v3.8.0.1
Patents (Details Narrative) - USD ($)
3 Months Ended
Mar. 31, 2018
Dec. 31, 2017
Common stock, par value $ 0.001 $ 0.001
Shares issued for purchase of patents $ 950,000  
Spirulinex, LLC [Member]    
Shares issued for purchase of patents, shares 200,000  
Common stock, par value $ 0.001  
Shares issued for purchase of patents $ 350,000